학술논문

Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton-Pump Inhibitors
Document Type
Article
Source
In: Clinical Pharmacology in Drug Development. (Clinical Pharmacology in Drug Development, November 2022, 11(11):1294-1307)
Subject
Language
English
ISSN
21607648
2160763X